| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/04/2008 | WO2007010256A9 Agents for and method of quantifying multiple related components in a biological system |
| 09/04/2008 | WO2006102233A3 Method and apparatus for imaging target components in a biological sample using permanent magnets |
| 09/04/2008 | US20080216180 Animal model for cancer, methods of producing the same and associated methods of use |
| 09/04/2008 | US20080215251 Computational method for choosing nucleotide sequences to specifically silence genes |
| 09/04/2008 | US20080215250 Molecular toxicology modeling |
| 09/04/2008 | US20080215249 Crystallization and structure determination of beta secretase and/or beta secretase-like proteins |
| 09/04/2008 | US20080215247 Machine and Procedure For Extracorporeal Treatment of Blood |
| 09/04/2008 | US20080214956 Methods and apparatus for lancet actuation |
| 09/04/2008 | US20080214811 Xanthene dyes |
| 09/04/2008 | US20080214788 Interferon-like protein zcyto21 |
| 09/04/2008 | US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders |
| 09/04/2008 | US20080214784 Human t1r2 taste receptor polypeptides |
| 09/04/2008 | US20080214662 Methods for the treatment of dementia based on apo e genotype |
| 09/04/2008 | US20080214596 Determining the level of expression and/or phosphorylation state of S6;rapamycin; antitumor |
| 09/04/2008 | US20080214584 Method for treating cancer |
| 09/04/2008 | US20080214569 Use of phosphatases to treat tumors overexpressing N-CoR |
| 09/04/2008 | US20080214482 Retromer-based assays and methods for treating alzheimer's disease |
| 09/04/2008 | US20080214471 Method for inhibition of viral infection |
| 09/04/2008 | US20080214468 Administering a peptide, identified through a phage display library; osteogenesis, cell adhesion/angiogenesis, inhibiting cancer cell metastasis |
| 09/04/2008 | US20080214458 Administering a modulator that interacts with a neurotransmitter receptor; synapse-specific proteins, Rab3A, NMDA-1, synapsin-1, tetanus toxin receptor, BDNF-receptor and a GABA receptor |
| 09/04/2008 | US20080214457 Isolated peptide, polynucleotide that encodes a peptide that is from 10 to 100 amino acids in length |
| 09/04/2008 | US20080214412 Method and device for preparing and/or analyzing biochemical reaction carriers |
| 09/04/2008 | US20080214403 Parallel Methods For Insertional Mutagenesis |
| 09/04/2008 | US20080213922 Using binding characteristics of tumor antigen as evaluative tool in isolation of preferential cell surface protein |
| 09/04/2008 | US20080213921 Immunoassay Methods |
| 09/04/2008 | US20080213920 Diagnostic detection device |
| 09/04/2008 | US20080213919 Functionalized fluorescent nanocrystals, and methods for their preparation and use |
| 09/04/2008 | US20080213918 Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof |
| 09/04/2008 | US20080213917 Hydroxy-isophthalamide moieties; antibodies; high stability, luminescence; kits |
| 09/04/2008 | US20080213916 Allosterically Catalyzed Signal Amplification in Chemical and Biological Sensing |
| 09/04/2008 | US20080213914 Method and system for measuring ron and mon values for light distillates |
| 09/04/2008 | US20080213912 Using electrophoretic-gel/gradient and micro-constricting microfluidic channels to extend relaxed segments of DNA |
| 09/04/2008 | US20080213911 Method of Analyzing C-Terminal Amino Acid Sequence of Peptide |
| 09/04/2008 | US20080213910 Method for blocking non-specific protein binding on a functionalized surface |
| 09/04/2008 | US20080213909 Determining adsorption of drug to pharmaceutical packaging surface comprising; exposing packaging surface to labeled or unlabeled drug, washing surface, remove bound drug and quantify with fluorescent analysis |
| 09/04/2008 | US20080213907 Protein markers for the diagnosis and prognosis of ovarian and breast cancer |
| 09/04/2008 | US20080213906 Compositions and methods for combining protein precipitation and solid phase extraction |
| 09/04/2008 | US20080213905 Methods of assessing the need for and the effectiveness of therapy with antioxidants |
| 09/04/2008 | US20080213904 Monitoring drug compliance, food-intake or toxin-intake using non-invasively-read labels |
| 09/04/2008 | US20080213893 Isolation of neural stem cells using gangliosides and other surface markers |
| 09/04/2008 | US20080213880 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 09/04/2008 | US20080213879 Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
| 09/04/2008 | US20080213875 Assay devices and methods |
| 09/04/2008 | US20080213861 Using targeted gene expression inhibition to treat and prevent viral infection |
| 09/04/2008 | US20080213859 Methods for the Reduction of Stutter in Microsatellite Amplification |
| 09/04/2008 | US20080213824 Fluorescence in situ hybridization staining employing an aqueous acetonitrile/dimethylsulfoxide mixture in fluorophore coupling reaction |
| 09/04/2008 | US20080213822 Methods for diagnosing celiac sprue and reagents useful therein |
| 09/04/2008 | US20080213820 Using channel protein activation as evaluative tool in determining concentration of muscle contration antagonist; diagnosing smooth muscle disorders |
| 09/04/2008 | US20080213818 Cellular immunity test with peptides attached to a solid support |
| 09/04/2008 | US20080213817 Enhancement of Th2-Dependent and Inflammatory Response |
| 09/04/2008 | US20080213811 Sensor proteins and assay methods |
| 09/04/2008 | US20080213807 Methods of Using Bone Morphogenic Proteins as Biomarkers for Determining Cartilage Degeneration and Aging |
| 09/04/2008 | US20080213806 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 09/04/2008 | US20080213805 Method for Distinguishing Follicular Thyroid Adenoma (FTA) from Follicular Thyroid Carcinoma (FTC) |
| 09/04/2008 | US20080213804 Parallel Processing Fluidic Method and Apparatus for Automated Rapid Immunohistochemistry |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213802 Diagnosis of Neurodegenerative Diseases |
| 09/04/2008 | US20080213801 Monomeric streptavidin muteins |
| 09/04/2008 | US20080213800 Method for Examing Interstitital Cystitis |
| 09/04/2008 | US20080213799 Identifying nuclear receptor ligands via change in receptor/cofactor binding affinities; drug screening for breast cancer therapeutics |
| 09/04/2008 | US20080213798 Novel c. elegans p21-activated kinase (pak) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of pak activity in the nematode, caenorhabditis elegans |
| 09/04/2008 | US20080213797 Bioassay with decreased antibody non-responsiveness for use in detecting and quantifying hepatitis-b surface antigen |
| 09/04/2008 | US20080213796 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity |
| 09/04/2008 | US20080213795 Plasmodium epitope polypeptide for use in treatment and prevention malarial infection |
| 09/04/2008 | US20080213794 Screening for gestational disorders |
| 09/04/2008 | US20080213793 Antibodies that bind receptor protein designated 2f1 |
| 09/04/2008 | US20080213791 Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer |
| 09/04/2008 | US20080213786 Using lectin modulators as treatments for cell proliferative and inflammatory disorders |
| 09/04/2008 | US20080213783 Binding oxidoreductases, peroxidases with oxidation/reduction agents; immunohistochemistry; kits |
| 09/04/2008 | US20080213778 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/04/2008 | US20080213776 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 09/04/2008 | US20080213775 Using presence of variation in methylenetetrahydrofolate dehydrogenase as evaluative tool in diagnosis/prognosis of pregnancy-related disorders |
| 09/04/2008 | US20080213765 Human Autism Susceptibility Genes Encoding a Neurotransmitter Transporter and Uses Thereof |
| 09/04/2008 | US20080213761 Using G-protein coupled receptors to identify modulators of flavors; enhancing drug and food palatability |
| 09/04/2008 | US20080213759 Novel Angiogenesis Inhibitor |
| 09/04/2008 | US20080213757 Methods of Distinguishing Types of Spinal Neurons Using Corl1 Gene as an Indicator |
| 09/04/2008 | US20080213755 Apparatus which utilizes cyclic DNA propagation for determining genotype of preferential samples |
| 09/04/2008 | US20080213754 Method of Amplifying Atp and Use Thereof |
| 09/04/2008 | US20080213751 Ilcs based pattern recognition of sepsis |
| 09/04/2008 | US20080213748 Automated high throughput bioassay for diagnostics; electrophoretic complexing of microbial proteins; electron or light microscopy |
| 09/04/2008 | US20080213747 Fluorescent dyes for use as reporter molecules in detection of preferential particles, cells and/or organisms in sample |
| 09/04/2008 | US20080213746 Methods of Diagnosis and Risk Stratification of Adverse Events in Post Myocardial Infarction Patients Using Pro-adrenomedullin |
| 09/04/2008 | US20080213694 Acid generator mixture is a diphenyl iodinium mesylate, tosylate or perfluorobutylsulfonate salt, a nonionic fluoroaliphatic polymer ester surfactant and N-methylpyrrolidone; solid phase synthesis of DNA, RNA, peptide nucleic acids, locked nucleic acids, or proteins for chips; photolithography |
| 09/04/2008 | US20080213438 reducing the degradation of sorbate solutions during storage in beverages containing ascorbic acid in the presence of certain transition metals utilize a blend of aqueous solutions of sodium benzoate and potassium sorbate, in an approximate 50%/50% by weight solution |
| 09/04/2008 | US20080213427 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 09/04/2008 | US20080213301 Compositions and methods for healthy pregnancy |
| 09/04/2008 | US20080213294 Immunization of dairy cattle with GapC protein against streptococcus infection |
| 09/04/2008 | US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 09/04/2008 | US20080213286 Composition comprising mastermind domain (MAM) polypeptide for use in treatment of cardiovascular and cell proliferative disorders |
| 09/04/2008 | US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 09/04/2008 | US20080213279 Blocking Leukocyte Emigration and Inflammation By Interfering With Cd99l2 |
| 09/04/2008 | US20080213277 Peptide hormone specific monoclonal antibody for use in diagnosis, prognosis, prevention and treatment of blood, cell proliferative, inflammatory, kidney and liver disorders |
| 09/04/2008 | US20080213276 G-protein coupled receptor specific immunoglobulin for use in treatment of neurodegenerative, spinal cord, psychological disordrers |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213271 Using dopamine receptor specific immunoglobulin to enhance dopaminergic neurotransmission and treat or prevention nervous system and/or neuropsyciatric disorders |
| 09/04/2008 | US20080213270 Using concentration of preferential neurotransmitter as diagnostic indicator of enterotoxin infection |
| 09/04/2008 | US20080213269 Preventive and/or Treating Agent for Cancer |
| 09/04/2008 | US20080213267 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 09/04/2008 | US20080213265 Human cytomegalovirus neutralising antibodies and use thereof |
| 09/04/2008 | US20080213259 Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30L |